122 related articles for article (PubMed ID: 34906469)
1. Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history.
Hassanin E; May P; Aldisi R; Spier I; Forstner AJ; Nöthen MM; Aretz S; Krawitz P; Bobbili DR; Maj C
Genet Med; 2022 Mar; 24(3):576-585. PubMed ID: 34906469
[TBL] [Abstract][Full Text] [Related]
2. Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence.
Hassanin E; Spier I; Bobbili DR; Aldisi R; Klinkhammer H; David F; Dueñas N; Hüneburg R; Perne C; Brunet J; Capella G; Nöthen MM; Forstner AJ; Mayr A; Krawitz P; May P; Aretz S; Maj C
BMC Med Genomics; 2023 Mar; 16(1):42. PubMed ID: 36872334
[TBL] [Abstract][Full Text] [Related]
3. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
4. Polygenic risk score (PRS) and its potential for breast cancer risk stratification.
Hovhannisyan M; Kleiblová P; Nehasil P; Soukupová J; Zemánková P; Kleibl Z; Janatová M
Klin Onkol; 2023; 36(3):198-205. PubMed ID: 37353348
[TBL] [Abstract][Full Text] [Related]
5. Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years.
Plym A; Zhang Y; Stopsack KH; Jee YH; Wiklund F; Kibel AS; Kraft P; Giovannucci E; Penney KL; Mucci LA
Clin Cancer Res; 2022 Nov; 28(22):4926-4933. PubMed ID: 36103261
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
Plym A; Penney KL; Kalia S; Kraft P; Conti DV; Haiman C; Mucci LA; Kibel AS
J Natl Cancer Inst; 2022 May; 114(5):771-774. PubMed ID: 33792693
[TBL] [Abstract][Full Text] [Related]
7. Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score.
Gao C; Polley EC; Hart SN; Huang H; Hu C; Gnanaolivu R; Lilyquist J; Boddicker NJ; Na J; Ambrosone CB; Auer PL; Bernstein L; Burnside ES; Eliassen AH; Gaudet MM; Haiman C; Hunter DJ; Jacobs EJ; John EM; Lindström S; Ma H; Neuhausen SL; Newcomb PA; O'Brien KM; Olson JE; Ong IM; Patel AV; Palmer JR; Sandler DP; Tamimi R; Taylor JA; Teras LR; Trentham-Dietz A; Vachon CM; Weinberg CR; Yao S; Weitzel JN; Goldgar DE; Domchek SM; Nathanson KL; Couch FJ; Kraft P
J Clin Oncol; 2021 Aug; 39(23):2564-2573. PubMed ID: 34101481
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
Dite GS; Spaeth E; Murphy NM; Allman R
Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
[TBL] [Abstract][Full Text] [Related]
9. Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk.
Darst BF; Sheng X; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA
Eur Urol; 2021 Aug; 80(2):134-138. PubMed ID: 33941403
[TBL] [Abstract][Full Text] [Related]
10. Potential of polygenic risk scores for improving population estimates of women's breast cancer genetic risks.
Wolfson M; Gribble S; Pashayan N; Easton DF; Antoniou AC; Lee A; van Katwyk S; Simard J
Genet Med; 2021 Nov; 23(11):2114-2121. PubMed ID: 34230637
[TBL] [Abstract][Full Text] [Related]
11. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
[TBL] [Abstract][Full Text] [Related]
12. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
Elife; 2022 Jul; 11():. PubMed ID: 35801699
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
Li H; Feng B; Miron A; Chen X; Beesley J; Bimeh E; Barrowdale D; John EM; Daly MB; Andrulis IL; Buys SS; Kraft P; ; Thorne H; Chenevix-Trench G; Southey MC; Antoniou AC; James PA; Terry MB; Phillips KA; Hopper JL; Mitchell G; Goldgar DE
Genet Med; 2017 Jan; 19(1):30-35. PubMed ID: 27171545
[TBL] [Abstract][Full Text] [Related]
14. Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.
Muranen TA; Mavaddat N; Khan S; Fagerholm R; Pelttari L; Lee A; Aittomäki K; Blomqvist C; Easton DF; Nevanlinna H
Breast Cancer Res Treat; 2016 Aug; 158(3):463-9. PubMed ID: 27438779
[TBL] [Abstract][Full Text] [Related]
15. Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening.
Lu T; Zhou S; Wu H; Forgetta V; Greenwood CMT; Richards JB
Genet Med; 2021 Mar; 23(3):508-515. PubMed ID: 33110269
[TBL] [Abstract][Full Text] [Related]
16. Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
Borde J; Laitman Y; Blümcke B; Niederacher D; Weber-Lassalle K; Sutter C; Rump A; Arnold N; Wang-Gohrke S; Horváth J; Gehrig A; Schmidt G; Dutrannoy V; Ramser J; Hentschel J; Meindl A; Schroeder C; Wappenschmidt B; Engel C; Kuchenbaecker K; Schmutzler RK; Friedman E; Hahnen E; Ernst C
BMC Cancer; 2022 Jun; 22(1):706. PubMed ID: 35761208
[TBL] [Abstract][Full Text] [Related]
17. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
Giri VN; Hegarty SE; Hyatt C; O'Leary E; Garcia J; Knudsen KE; Kelly WK; Gomella LG
Prostate; 2019 Mar; 79(4):333-339. PubMed ID: 30450585
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women.
Mars N; Kerminen S; Tamlander M; Pirinen M; Jakkula E; Aaltonen K; Meretoja T; Heinävaara S; Widén E; Ripatti S;
J Clin Oncol; 2024 May; 42(13):1477-1487. PubMed ID: 38422475
[TBL] [Abstract][Full Text] [Related]
19. Uptake of polygenic risk information among women at increased risk of breast cancer.
Yanes T; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Young MA; James PA
Clin Genet; 2020 Mar; 97(3):492-501. PubMed ID: 31833054
[TBL] [Abstract][Full Text] [Related]
20. Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry.
Hughley RW; Matejcic M; Song Z; Sheng X; Wan P; Xia L; Hart SN; Hu C; Yadav S; Lubmawa A; Kiddu V; Asiimwe F; Amanya C; Mutema G; Job K; Ssebakumba MK; Ingles SA; Hamilton AS; Couch FJ; Watya S; Conti DV; Darst BF; Haiman CA
Cancer Res Commun; 2023 Dec; 3(12):2544-2550. PubMed ID: 38014910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
